Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Milanese

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Immunology Letters|December 3, 2014
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trialFulvio Braido, Giovanni Melioli, Piero Candoli, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 1, 2021
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational studyFulvio Braido, Francesco Blasi, Giorgio Walter Canonica, et al.
The World Allergy Organization Journal|October 1, 2020
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the <i>Severe Asthma Network in Italy</i> (<i>SANI</i>)Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2023
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi ConsensusGiorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Immunology Letters|December 3, 2014
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trialFulvio Braido, Giovanni Melioli, Piero Candoli, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 1, 2021
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational studyFulvio Braido, Francesco Blasi, Giorgio Walter Canonica, et al.
The World Allergy Organization Journal|October 1, 2020
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the <i>Severe Asthma Network in Italy</i> (<i>SANI</i>)Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2023
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi ConsensusGiorgio Walter Canonica, Francesco Blasi, Giovanna Elisiana Carpagnano, et al.
Pageof 8